Headquartered in New York, the technology and IP transactions department at Weil, Gotshal & Manges LLP is dedicated to engaging in sophisticated IP transactions involving technology and data innovations, including acquisitions, dispositions, joint ventures, licensing agreements, and outsourcing agreements. The practice group operates under the leadership of Charan Sandhu in New York, who concentrates on the development, acquisition, and commercialization of technology-related IP on behalf of established businesses. Also based in New York is Olivia Greer, head of the US private and cybersecurity practice, who focuses on cross-border transactions and evaluates cybersecurity risk in mergers and acquisitions and investments, and Dennis Adams, who advises high-value acquisitions and licensing agreements for technology clients.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘We have been working with Weil for 25 years! They continue to be a top-notch firm that always delivers expert advice and produces phenomenal work product. ’
‘Karen Ballack is the BEST! So incredibly responsive, brings in others when needed, and is an absolute pleasure to work with. ’
'Weil has a lot of experience in patent licensing, particularly in the pharma and semiconductor industries, with a strong bench of senior attorneys having done extensive work in this space.'
'Dennis Adams is an energetic lawyer with a calm demeanor and a willingness to pay careful attention to client needs and expectations to achieve great results for his clients.'
Key clients
- Advent International
- Bain Capital
- Bell Canada
- Brookfield Asset Management
- ChampionX Corporation
- Dun & Bradstreet Holdings, Inc.
- Foundation Building Materials, LLC
- Giant Eagle, Inc.
- Goldman Sachs
- Halozyme Therapeutics, Inc.
- The Home Depot Inc.
- Iodine Software
Work highlights
Advised Sanofi on the technology, data privacy and IP aspects of its $9.5 billion acquisition of Blueprint Medicines, a US-based, publicly traded biopharmaceutical company specializing in systemicmastocytosis (SM), a rare immunological disease, and other KIT-driven diseases.
Advised Foundation Building Materials (FBM), as well as its private equity sponsor owners American Securities LLC and Clayton Dubilier & Rice, LLC, on the technology, data privacy and IP aspects of FBM’s $8.8 billion sale to Lowe’s Companies, Inc. FBM is a leading North American distributor of interior building products, including drywall, metal framing, ceiling systems, commercial doors and hardware, insulation and complementary products serving large residential and commercial professionals in both new construction and repair and remodel applications.
Advised Dun & Bradstreet Holdings, Inc., a supplier of data and analytics solutions and insights that are used in making commercial credit and other business decisions, on the technology, data privacy and IP aspects of its sale to Clearlake Capital Group, L.P. in a transaction valued at $7.7 billion (including outstanding debt / with an equity value of $4.1 billion.)
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Charan Sandhu
Other key lawyers
Olivia Greer; Dennis Adams; Karen Ballack; Max Scott